期刊文献+

瓣膜性心脏病伴永久性心房颤动患者术中消融疗效的分析 被引量:2

Surgical Ablation of Permanent Atrial Fibrillation in Patients With Valvular Heart Diseases
暂未订购
导出
摘要 目的:明确在对瓣膜性心脏病伴永久性心房颤动(房颤)患者的手术中进行房颤消融的有效性,以及影响消融成功率的主要因素。方法:从2005-09至2007-12,对57例患者施行了瓣膜手术,并在术中进行了房颤消融。术前测量患者的左心室射血分数、左心室收缩末期容积、左心室舒张末期容积、左心房直径、肺动脉压,并与年龄、性别、主动脉阻断时间。术后进行随访,分析影响消融成功的关键因素。结果:全组围手术期死亡2例,随访2~24个月,保持窦性心律者为39例(70.9%,n=55)。结论:在瓣膜手术中施行房颤消融安全、有效,影响消融成功率的唯一因素为左心房大小。 Objective :To evaluate the efficacy of surgical ablation in patients with permanent atrial fibrillation and valvular heart diseases, and try to determine the key factors which affected the rate of success. Methods : A total of 57 patients with atrial fibrillation and valvular heart diseases from September 2005 to October 2006 were treated in our hospital by surgical ablation using radio frequency energy during concomitant heart valve operation. The patients' age ranged from 20 to 69 years,with 26 male and 31 female. Their left ventricular ejection fraction (LVEF) , left ventricular end systolic volume (LVESV), left ventricular end diastolic volume (LVEDV), left atrium diameter (LA) , pulmonary artery pressure (PAP), together with their age, gender and cross clamp time (CLAMP)were analyzed to determine the key factors which affected the surgical ablation results. Results:All patients were followed up from 2 to 24 months. There were 2 peri-operative deaths, and 39/55 (70. 9% )had sinus rhythm during the period of follow up time. Conclusion :The radio frequency ablation was an effective method to treat atrial fibrillation in patients with valvular heart diseases. The size of left atrium was the only factor related to the failure of the ablation procedure.
出处 《中国循环杂志》 CSCD 北大核心 2009年第2期120-122,共3页 Chinese Circulation Journal
关键词 射频消融 心脏瓣膜疾病 心脏手术 Radio fequency ablation Valvular heart disease Cardiac operation
  • 相关文献

参考文献10

  • 1Damiano Jr RJ,Gaynor S.Atrial fibrillation ablation during mitral valve surgery using the Atricure device.Operat Tech Thorac Cardiovasc Surg,2004,9:24.
  • 2Geidel S,Lass M,Boczor S,et al.Surgical treatment of permanent atrial fibrillation during heart valve surgery.Interact Cardiovasc Thorac Surg,2003,2(2):160-165.
  • 3Marui A,Nishina T,Tambara K,et al.A novel atrial volume reduction technique to enhance the Cox maze procedure:Initial results.J Thorac Cardiovasc Surg,2006,132 (5):1047 -1053.
  • 4Gillinov AM,McCarthy PM,Blackstone EH,et al.Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality.J Thorac Cardiovasc Surg,2005,129:1321-1328.
  • 5Cox JL,Boineau JP,Schuessler RB,et al.Successful surgical treatment of atrial fibrillation.Review and clinical update.J Am Med Assoc,1991,266:1976-1980.
  • 6Khargi K,Hutten BA,Lemke B,et al.Surgical treatment of atrial fibrillation; a systematic review.Eur J Cardiothorac Surg,2005,27:258.
  • 7Lall SC,Damiano RJ Jr.Surgical ablation devices for atrial fibrillation.J Interv Card Electrophysiol,2007,20 (3):73-82.
  • 8Kress DC:,Krum D,Chekanov V,et al.Validation of a left atrial lesion pattern for intraoperative ablation of atrial fibrillation.Ann Thorac Surg,2002,73:1160.
  • 9Martin-Suàrez S,Claysset B,Botta L,et al.Surgery for atrial fibrillation with radiofrequency ablation:four years experience.Interact Cardiovasc Thorac Surg,2007,6(1):71-76.
  • 10Cox JL,Schuessler RB,Lappas DG,et al.An 8 1/2 year clinical experience with surgery for atrial fibrillation.Ann Surg,1996,224:267.

同被引文献11

  • 1Cox JL, Schuessler RB, Boineau JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg,2000,12:2-14.
  • 2Prasad SM,Maniar HS,Camillo CJ,et al. The Cox maze ID procedure for atrial fibrillation; long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg, 2003 ,126: 1822-1828.
  • 3Barnett SD,Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg, 2006, 131:1029-1035.
  • 4Xu J,Cui G,Esmailian F,et al. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation, 2004,109:363-368.
  • 5Weber KT. Cardiac interstitium in health and disease;the fibrillar collagen network. J Am Coll Cardiol, 1989,13:1637-1652.
  • 6Wang W,Liu L,Li Y,et al. Does the Expression of Transforming Growth Factor beta-1; Affect the Outcome of the Radiofrequency Modified Maze Procedure in Patients with Rheumatic Atrial Fibrillation? Tex Heart Inst J,2012,39:17-23.
  • 7Kato K,Fujimaki T,Yoshida T,et al. Impact of matrix metalloprotein-ase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation. Europace, 2009, 11:332-337.
  • 8Grubitzsch H,Grabow C,Orawa H,et al. Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation. Eur J Cardiothorac Surg,2008,34:67-72.
  • 9Sie HT, Beukema WP,Misier AR,et al. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg,2001,122:249-256.
  • 10石开虎,宣海洋,吴君旭,张飞,徐盛松,曹炜,龚文辉,赵旭东,占红英.附加扩大左房减容与直流电转复模式对瓣膜病合并心房颤动患者心房颤动的影响[J].中国心脏起搏与心电生理杂志,2010,24(6):521-523. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部